Get the Stockscreener App
10.79
0.65%
0.07
Helix Acquisition Corp Ii stock is traded at $10.79, with a volume of 914.
It is up +0.65% in the last 24 hours and up +0.84% over the past month.
Helix Acquisition Corp II is a Blank check company.
See More
Previous Close:
$10.72
Open:
$10.75
24h Volume:
914
Relative Volume:
0.02
Market Cap:
$253.66M
Revenue:
-
Net Income/Loss:
$3.27M
P/E Ratio:
64.26
EPS:
0.1679
Net Cash Flow:
$-647.10K
1W Performance:
+0.00%
1M Performance:
+0.84%
6M Performance:
+3.75%
1Y Performance:
+3.75%
1-Day Range:
$10.74
$10.79
1-Week Range:
$10.66
$10.85
52-Week Range:
$10.14
$11.59
Helix Acquisition Corp Ii Stock (HLXB) Company Profile
Name
Helix Acquisition Corp Ii
Sector
Industry
Phone
857 702 0377
Address
C/O CORMORANT ASSET MANAGEMENT, LP, BOSTON
Compare HLXB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLXB
Helix Acquisition Corp Ii
|
10.79 | 253.66M | 0 | 3.27M | -647.10K | 0.1679 |
|
LION
Lionsgate Studios Corp
|
7.56 | 2.18B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.16 | 697.50M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.62 | 457.99M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.22 | 449.41M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.05 | 447.95M | 0 | 0 | 0 | 0.00 |
Helix Acquisition Corp Ii Stock (HLXB) Latest News
Helix Acquisition Corp. II SEC 10-K Report - TradingView
BBIOBridgebio Pharma Latest Stock News & Market Updates - StockTitan
Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics - Global Legal Chronicle
Newsroom - White & Case LLP
BridgeBio Oncology and Helix enter definitive merger agreement - MSN
BridgeBio spin-out in SPAC deal to target RAS and PI3Kα malignancies - The Pharma Letter
White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics - White & Case LLP
Helix Acquisition Corp. II (HLXB) to Combine with BridgeBio Oncology in $360M Deal - SPACInsider
Helix Acquisition Corp. II Merger with BridgeBio Oncology Therapeutics - Leerink Partners
Finance Watch: BridgeBio’s Oncology Spinout Reveals Go-Public Plan - Citeline News & Insights
LZ Technology Closes $7.2 Million IPO -February 28, 2025 at 04:48 pm EST - Marketscreener.com
BridgeBio spinout to go public in SPAC deal with Helix Acquisition Corp. II - MSN
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs - MedCity News
Boston SPAC picks biotech to take public - The Business Journals
Goodwin, White & Case Build BridgeBio's $949M SPAC Deal - Law360
BridgeBio oncology spinout to go public in blank-check merger - BioPharma Dive
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal - BioSpace
Helix Acquisition to Merge With BridgeBio Oncology Therapeutics -February 28, 2025 at 09:37 am EST - Marketscreener.com
BridgeBio's KRAS-focused cancer spinout backs SPAC as path to Nasdaq - Fierce Biotech
BridgeBio Oncology Therapeutics and Helix Acquisition Corp. II To Merge - citybiz
BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen - Endpoints News
$450M Deal Powers New Cancer-Fighting Biotech: What's Inside BridgeBio's Oncology SPAC Merger? - StockTitan
Fifth Era Acquisition Corp. I (FERAU) Prices $200M IPO - SPACInsider
NewHold Investment Corp. III (NHICU) Prices $175M IPO - SPACInsider
Live Oak Acquisition Corp. V (LOKVU) Prices $200M IPO - SPACInsider
Wall Street Sentiment Positive After Nvidia Earnings, Lifting US Equity Futures Pre-Bell - Marketscreener.com
Rithm Acquisition Corp. (RAC.U) Prices $200M IPO - SPACInsider
Helix Acquisition Corp. II appoints new independent director - MSN
Blank Check Co Sichuan Hongyi Enterprise Management Co Ltd Files For IPO Of Up To $100 Mln - Marketscreener.com
Podcast: Inside the Private Markets with Nick Fusco, Founder & CEO of PM Insights - SPACInsider
EQT has sold Waystar shares for $ 393 million -February 25, 2025 at 12:34 am EST - Marketscreener.com
10 Oversold Pharma Stocks to Buy According to Analysts - Insider Monkey
Investors Await Business Activity, Home Sales Data as US Equity Futures Point to Mixed Open for Wall Street - Marketscreener.com
Wellgistics Health Prices $4 Million IPO -February 21, 2025 at 08:26 am EST - Marketscreener.com
Hyzon Motors Plans to Delist From Nasdaq -February 21, 2025 at 03:50 am EST - Marketscreener.com
BridgeBio: Strong Start For Attruby (NASDAQ:BBIO) - Seeking Alpha
12 Most Oversold Healthcare Stocks to Buy Now - Insider Monkey
Stocks Down Pre-Bell Ahead of Latest Retail Sales Report; Asia, Europe Mostly Up -February 14, 2025 at 07:12 am EST - Marketscreener.com
BridgeBio Earnings Preview: First Attruby Sales Data and Clinical Pipeline Milestones Ahead - StockTitan
Robot Consulting Files For US IPO -February 12, 2025 at 05:45 pm EST - Marketscreener.com
Helix Acquisition Corp. II Appoints Albert A. Holman, III to Board of Directors - Defense World
Capital One Financial Corp (NYSE: COF) Announces Merger Agreement with Discover Financial Services - Defense World
Equities Analysts Issue Forecasts for Equifax Q3 Earnings - Defense World
William Blair Issues Pessimistic Estimate for JKHY Earnings - Defense World
Roth Capital Has Negative Estimate for Alphabet Q3 Earnings - Defense World
Atb Cap Markets Analysts Lift Earnings Estimates for NOV - Defense World
Q3 Earnings Forecast for Ero Copper Issued By Raymond James - Defense World
Q3 EPS Estimates for Aviat Networks Reduced by Analyst - Defense World
Seaport Res Ptn Issues Optimistic Estimate for HONE Earnings - Defense World
What is Leerink Partnrs’ Estimate for ZNTL Q3 Earnings? - Defense World
Keefe, Bruyette & Woods Estimates Meritage Homes Q3 Earnings - Defense World
Helix Acquisition Corp Ii Stock (HLXB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):